-+ 0.00%
-+ 0.00%
-+ 0.00%

Karyopharm Therapeutics Signs Forbearance Agreement, Limited Waiver To Indentures For Additional Time To Advance Its Myelofibrosis Program; Did Not Pay $15.8M Due Under Sept. 10 Credit Agreement

Benzinga·09/11/2026 11:51:55
Listen to the news

https://www.sec.gov/ix?doc=/Archives/edgar/data/1503802/000119312526388621/d94769d8k.htm